|
|
Office Locations:
|
1000 Wilson Blvd., Suite 3000
Arlington, VA 22209
Phone: 703-562-4000
| | |
|
|
|
|
|
Consumer Products & Services
Information Technology
Life Sciences & Healthcare
|
|
|
|
Sands Capital Ventures invests in promising businesses in three dynamic, high-growth markets: Life Sciences, Technology, and Global Consumer. The firm is the venture capital affiliate of Sands Capital Management, an investment firm founded in 1992 that manages long-only, concentrated public company portfolios. An independent, staff-owned firm based in the Greater Washington, DC area, Sands Capital managed more than $52 billion* in client assets as of December 31, 2023. Sands' Private Growth strategy targets growth equity investments in highly innovative, mid-late stage technology companies. The firm typically seeks a $25 million to $100 million target investment size per company.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
